Location History:
- Cupertion, CA (US) (1987)
- Cupertino, CA (US) (1978 - 1997)
- Palo Alto, CA (US) (1976 - 2002)
Company Filing History:
26 out of 932 
1 out of 47 
1 out of 832,843 Years Active: 1976-2002
Title: The Innovative Contributions of Gordon H. Jones in Lipid Chemistry
Introduction: Gordon H. Jones, based in Cupertino, California, is an esteemed inventor with an impressive portfolio of 28 patents. His innovations primarily focus on specialized compounds and their applications in the field of chemistry, particularly in relation to lipids and pharmaceuticals.
Latest Patents: Among his latest patented inventions are compounds categorized as N-[1,(1-1)-dialkyloxy] and N-[1,(1-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids. These compounds are remarkable for their pharmaceutical applications, involving complex structures where R1 and R2 represent alkyl or alkenyl groups ranging from 6 to 24 carbon atoms. Additionally, R3, R4, and R5 can vary in their constitution, including alkyl groups with 1 to 8 carbon atoms, aryl groups, or even larger structures like quinuclidino and piperidino. These inventions emphasize the intricate chemistry and potential medical applications within the pharmaceutical industry.
Career Highlights: Gordon H. Jones has had a fruitful career with significant contributions while working at Syntex (U.S.A.) Inc. and Syntex LLC. His extensive experience in these prominent companies has allowed him to refine his expertise in lipid chemistry and lead innovative projects that impact the pharmaceutical sector.
Collaborations: Throughout his career, Gordon has collaborated with notable professionals in his field, including Deborah A. Eppstein and Philip L. Felgner. These partnerships have facilitated the sharing of knowledge and expertise, enhancing the development of new compounds and their applications.
Conclusion: Gordon H. Jones's dedication to innovation in lipid chemistry showcases the importance of research and collaboration in bringing new inventions to life. With a track record of 28 patents, his contributions continue to influence advancements in the pharmaceutical industry, paving the way for future discoveries and applications.